LivFul
Temple, US · Founded 2021 · Texas corporation
Founders & leadership
HB
Hogan BasseyExecutive
ME
Matt ElsberryExecutive
JM
John ManwellExecutive
MN
Michael NormanExecutive
FY
Francis YipExecutive
Board
CT
Carl ThongBoard director
YN
Yaw NsarkohBoard director
KM
Kris MaynardBoard director
AB
Andrew BarlowBoard director
WL
Wesley LyonsBoard director
DR
Dave RaeBoard director
Reported raises · per SEC filings
Form D private placements$10.1M disclosed across 4 rounds · 2021–2025
▶$250KraisedDec 2025 · 2 investors · PharmaceuticalsRule 506(b)
▶$250KraisedDec 2025 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Hogan BasseyExecutive Officer, Director
- Matt ElsberryExecutive Officer, Director
- Yaw NsarkohDirector
- John ManwellExecutive Officer, Director
- Kris MaynardDirector
- Michael NormanExecutive Officer, Director
- Andrew BarlowDirector
- Carl ThongDirector
- Offering amount
- $26M
- Amount sold
- $250K
- Minimum investment
- $250K
- First sale
- Dec 2025
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
▶$125KraisedJun 2024 · 1 investors · PharmaceuticalsRule 506(b)
▶$125KraisedJun 2024 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael NormanExecutive Officer, Director
- Yaw NsarkohExecutive Officer, Director
- Wesley LyonsDirector
- Hogan BasseyExecutive Officer, Director
- John ManwellExecutive Officer, Director
- Kris MaynardDirector
- Kevin EngelExecutive Officer, Director
- Matt ElsberryExecutive Officer, Director
- Offering amount
- $6.5M
- Amount sold
- $125K
- First sale
- May 2024
- Incorporated
- Corporation, Texas, 2021
- Federal exemptions
- 06b
▶$3.1MraisedApr 2023 · 13 investors · PharmaceuticalsRule 506(b)
▶$3.1MraisedApr 2023 · 13 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Wesley LyonsDirector
- Francis YipExecutive Officer, Director
- John ManwellExecutive Officer, Director
- Michael NormanExecutive Officer, Director
- Dave RaeDirector
- Hogan BasseyExecutive Officer, Director
- Matt ElsberryExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $3.1M
- First sale
- May 2022
- Incorporated
- Corporation, Texas, 2021
- Federal exemptions
- 06b
▶$6.7MraisedMar 2021 · 60 investors · PharmaceuticalsRule 506(b)
▶$6.7MraisedMar 2021 · 60 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Dave RaeDirector
- Francis YipExecutive Officer, Director
- Matt ElsberryExecutive Officer, Director
- Hogan BasseyExecutive Officer, Director
- John ManwellExecutive Officer, Director
- Michael NormanExecutive Officer, Director
- Offering amount
- $10.7M
- Amount sold
- $6.7M
- First sale
- Mar 2021
- Incorporated
- Corporation, Texas, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has LivFul raised?
- LivFul has disclosed $10.1M raised across 4 rounds.
- Where is LivFul headquartered?
- LivFul is headquartered in Temple, US.